Importantly, successful treatment with a recombinant IL-18 binding protein (IL-18BP) has been reported in 1 patient with autoinflammation with infantile enterocolitis (AIFEC; OMIM 616050), an NLRC4-AID.11 Here, NLRC4 is linked to periodic fever-infantile enterocolitis-autoinflammatory syndrome.